A retrospective analysis of Sorafenib treatment with and without Transarterial Chemoembolization for Advanced Hepatocellular Carcinoma (HCC) With Main Portal Vein Tumor Thrombosis (MPVTT).
Phase of Trial: Phase IV
Latest Information Update: 27 Oct 2016
At a glance
- Drugs Sorafenib (Primary)
- Indications Liver cancer
- Focus Adverse reactions; Therapeutic Use
- 27 Oct 2016 New trial record